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Increased free radical formation and altered redox
state are of fundamental importance in the pathogenesis
of autoimmune diseases including Systemic Lupus
Erythematos (SLE). Free radicals are mainly derived
from oxygen (Reactive Oxygen Species/ROS) and
nitrogen (Reactive Nitrogen
Species/RNS) at
mitochondria, cellular membranes and the endoplasmic
reticulum membrane as physiological responses to a
variety of internal and external stress (Shah et al.,
2011b). At low levels, they act as signalling molecules
and at high levels, they damage organelles, particularly
the mitochondria and causes irreversible damage to
lipids, DNA and proteins, thus provoking cell death
through several modes, including apoptosis and necrosis
(Shah et al., 2013). In the last 2 decades, there has been
substantial progress in understanding the mechanism of
oxidative stress in pathogenesisof SLE and level of
intracellular glutathione has been regarded as a
checkpoint of oxidative stress (Shah et al., 2014).
Altered signal transduction; mTOR is activated by
relative depletion of glutathione and supplementation of
N-Acetyl Cysteine (NAC), a precursor of glutathione,
replenishs intracellular glutathione and inhibitsmTOR
signaling and diminished oxidative stress mediated
damage in SLE (Fernandez and Perl, 2010).
Management of disease through supplement of NAC
andrapamycin has been showing promising therapy in
SLE patients. Recently, several lines of evidence from
genetic, cell biology and lupus animal model studies
suggests a pivotal role of autophagy in mediating the
occurrence and development of SLE (Alessandri et al.,
2012). Interestingly, autophagy is regulated by mTOR
pathway and mTOR is activated by relative depletion of
glutathione. Thus, redox signaling may provide a link
between altered autophagy and depletion of glutathione
and autophagy regulation by replenishment of
intracellular glutathione may have a therapeutic
intervention for the management of disease.

We have shown that changes in the intracellular
redox environment of cells, through oxygen-derived free
radical production known as oxidative stress, have been
reported to be critical for cellular immune dysfunction
(Shah et al., 2010), activation of apoptotic enzymes and
apoptosis (Shah et al., 2013). Decreased intracellular
glutathione levels in the various blood components,
including total lymphocytes and its subsets (CD4, CD8 T
cell) are strongly associated with disease severity and
linked to increase Th1/Th2 cytokine imbalance and
lymphocyte apoptosis in SLE patients (Shah et al.,
2011a). Similarly, Tewthanom et al. (2009) reported that
administration of NAC may be beneficial in mild SLE
patients in terms of decreasing lipid peroxidation.
Lai et al. (2012) demonstrates that GSH regulates the
elevation of mitochondrial transmembrane potential
(∆ψm) or Mitochondrial Hyperpolarization (MHP),
which in turn activates the mammalian Target Of
Rapamycin (mTOR) in lupus T cells. mTOR skews cell
death
signal
processing,
modulates
T-cell
differentiation and, in particular, inhibits the
development of CD4 +/CD25 +/Foxp3 + regulatory T
cells which are deficient in patients with active SLE.
Nevertheless, studies of Fernandez and Perl (2010;
Lai et al., 2012) are certainly important as they
suggest the blockade of mTOR with rapamycin and
NACimproves lupus disease activity.
Over recent years, perturbation in autophagy has been
implicated in a number of diseases, including systemic
lupus erythematosus (Alessandri et al., 2012). Towns et al.
(2005) found that serum factors, likely autoantibodies,
purified from patients with SLE were able to induce
autophagy in neuroblastoma cell lines, providing a further
link between autophagy and SLE. Accordingly, several
other groups have reported the activated autophagy
pathway in T and B lymphocytes as a mechanism for
survival of autoreactive T and B lymphocytes. The
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inhibition of autophagy by blocking mTORsgnalling has
been suggested as a novel treatment target in this disease.
Importantly, Lai et al. (2012) has shown that
blockade of mTOR with supplementation of NAC
reversing glutathione depletion and improving disease
activity and fatigue in patients with SLE. NAC treatment
promotes expansion of CD4+CD25+FOXP3+ T-cell
subsets, inhibit anti-DNA antibody production. Indeed,
NAC reversed the expansion of CD4–CD8– T cells,
which exhibited the most prominent mTOR activation
before treatment with NAC and had been deemed
responsible for promoting anti-DNA autoantibody
production by B cells. They showed that NACacts as a
sensor of ∆Ψm, mTOR governs T-cell signalling events
implicated in the pathogenesis (Lai et al., 2012). Since,
activation of autophagy has been considered to be
principally regulated by mTOR pathway and
supplementation of NAC block mTOR signalling in SLE
patients. It will be intriguing to study the effect of
therapeutic supplement of NAC on autophagy in animal
models of Lupus and in SLE patients. Such kind of studies
encourage to explore more therapeutic potential of NAC
which might prove to provide an inexpensive and
significant alternative therapy in SLE.
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